Case Report / Olgu Sunumu
DISCUSSION
The mechanism underlying how clozapine causes leukocytosis remains unknown (4) . One possibility is that clozapine may stimulate the release of certain cytokines, including TNF, IL-2, IL-6, and G-CSF (5) . Other possible risk factors may be smoking, being male, and the use of lithium (6) . One study reported a case of a 50-year-old Caucasian male treated with clozapine for schizophrenia; the patient had a medical history of a head injury and a splenectomy. Prior to clozapine treatment, the patient had a normal WBC count of 5.2×10 9 /L with a normal differential. After reaching a target dose of 350 mg/day of clozapine, WBC count fluctuated between 5.2×10 9 /L and 12.2×10 9 /L. A WBC count of 15.6×10 9 /L was observed at week 16, without a sore throat, rash, or flu-like symptoms. From week 16 to week 23, the patient presented with intermittent leukocytosis; WBC count ranged from normal to significantly elevated (7) . Another study reported a case of a 41-year-old Caucasian male treated with clozapine for the stabilization of paranoid schizophrenia. A medical record review indicated a normal WBC count prior to the initiation of clozapine treatment, with leukocytosis (15.4×10 9 -24.4×10 9 /L) that manifested shortly thereafter and lasted for a period of eight years. However, leukocytosis was not attributed solely to clozapine in this case, as the patient was simultaneously receiving lithium therapy (8) . Madhusoodanan reported seven cases of chronic leukocytosis linked to clozapine (9) . None of the seven patients had any evidence of infection or other potential general medical conditions (trauma, burns, etc.) that might have increased WBC count. The peak WBC count reported for these seven patients was 19.8×10 9 /L; leukocytosis duration in these patients ranged from 2 to 5 years. The course for all patients was benign in nature, as there were no adverse effects associated with leukocytosis. Authors also considered chronic cigarette smoking and male gender as possible risk factors for leukocytosis (9) . Sopko and Caley (10) reported a 37-year-old Caucasian patient treated for refractory schizophrenia. The patient also had a history of obsessive compulsive disorder and substance abuse. During the following two-year period, WBC count fluctuated between 10×10 9 /L and 28×10 9 /L with a dose of 225-300 mg/ day. The authors found no medical condition to explain the leukocytosis (10) . Our patient was female and had no history of lithium use. Despite being a heavy smoker, there was no chronological relation between her leukocytosis and smoking. However, several studies have shown that cigarette smoking induces the metabolism of clozapine by cytochrome P4501A2 (CYP1A2); therefore, a potential interaction between clozapine and nicotine might underlie the development of leukocytosis (11, 12) .
In this paper we have reported a patient who developed leukocytosis during clozapine treatment. It appears that clozapine-associated leukocytosis is a benign medical condition. The clozapine-associated risk of agranulocytosis is well established; however, clinicians should also be cautious of the risk for other blood dyscrasias, such as leukocytosis.
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